Introduction of Soluble Proteins into the MHC Class I Pathway by Conjugation to an HIV tat Peptide

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1666-1668

  Kim, Dewey T ^a   Mitchell, Dennis J ^a   Brockstedt, Dirk G ^a   Fong, Lawrence ^a   Nolan, Garry P ^a   Fathman, C Garrison ^a   Engleman, Edgar G ^a   Rothbard, Jonathan B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; OVALBUMIN; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MOUSE; PHYSIOLOGY;

ANIMALS; DENDRITIC CELLS; GENE PRODUCTS, TAT; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; MICE; MICE, INBRED C57BL; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031571206     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Germain, R. N. 1995. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules: implications for development of combination vaccines. Ann. NY Acad. Sci. 754:114.
2. Heemels, M. T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
3. Kalish, R. S. 1995. Antigen processing: the gateway to the immune response. J. Am. Acad. Dermatol. 32:640.
4. Monaco, J. J. 1995. Pathways for the processing and presentation of antigens to T cells. J. Leukocyte Biol. 57:543.
5. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
6. Carbone, F. R., M. W. Moore, J. M. Sheil, and M. J. Bevan. 1988. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J. Exp. Med. 167:1767.
7. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by peptide immunization. J. Exp. Med. 169:603.
8. Nonacs, R., C. Humborg, J. P. Tam, and R. M. Steinman. 1992. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 176:519.
9. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189.
10. Fawell, S., J. Seery, Y. Daikh, C. Moore, L. L. Chen, B. Pepinsky, and J. Barsoum. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91:664.
11. Pepinsky, R. B., E. J. Androphy, K. Corina, R. Brown, and J. Barsoum. 1994. Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor. DNA Cell Biol. 13:1011.
12. Hill, C. M., A. Liu, K. W. Marshall, J. Mayer, B. Jorgensen, B. Yuan, R. M. Cubbon, E. A. Nichols, L. S. Wicker, and J. B. Rothbard. 1994. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152:2890.
13. Kim, D. T., J. B. Rothbard, D. D. Bloom, and C. G. Fathman. 1996. Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. J. Immunol. 156:2737.
14. + CTLs from naive precursors. J. Immunol. 153:996.
15. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
16. Powis, S. J., A. R Townsend, E. V. Deverson, J. Bastin, G. W. Butcher, and J. C. Howard. 1991. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354:528.
17. Allsopp, C. K., M. Plebanski, S. Gilbert, R. E. Sinden, S. Harris, G. Frankel, G. Dougan, C. Hioe, D. Nixon, K. Paoletti, G. Layton, and A. V. Hill. 1996. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 26:1951.
18. Hsu, F. J., C. Benike, F. Fagnoni, T. M. Liles, D. Czerwinski, B. Taidi, E. G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52.
19. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Tielenians, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
20. Zitvogel, L., J. I. Mayordomom, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87.
21. Paglia, P., C. Chiodoni, M. Rodolfo, and M. P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317.
22. Elbe, A., and G. Stingl. 1995. Dendritic cells as stimulator cells of MHC class I-restricted immune responses. Adv. Exp. Med. Biol. 378:341.
23. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
24. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cylotoxic T lymphocytes. J. Exp. Med. 182:255.
25. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. B. Deleo, and M. T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297.
26. Norbury, C. C., L. J. Hewlett, A. R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783.